
Home » Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance
October 28, 2013
Senesco has enrolled its first patients at a new clinical trial site in Seattle. The company is beginning a Phase Ib/IIa trial of its SNS01-T drug for B-cell cancer.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
27Jan
-
27Jan
-
09Feb
-
10Feb
-
11Feb
-
17Feb